Wednesday, September 21, 2016

Vibramycin


Vibramycin is a brand name of doxycycline, approved by the FDA in the following formulation(s):


VIBRAMYCIN (doxycycline - for suspension; oral)



  • Manufacturer: PFIZER

    Approved Prior to Jan 1, 1982

    Strength(s): EQ 25MG BASE/5ML [RLD][AB]

VIBRAMYCIN (doxycycline calcium - suspension; oral)



  • Manufacturer: PFIZER

    Approved Prior to Jan 1, 1982

    Strength(s): EQ 50MG BASE/5ML [RLD]

VIBRAMYCIN (doxycycline hyclate - capsule; oral)



  • Manufacturer: PFIZER

    Approved Prior to Jan 1, 1982

    Strength(s): EQ 100MG BASE [RLD][AB], EQ 50MG BASE [AB]

Has a generic version of Vibramycin been approved?


Yes. The following products are equivalent to Vibramycin:


doxycycline for suspension; oral



  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: July 16, 2008

    Strength(s): EQ 25MG BASE/5ML [AB]

doxycycline hyclate capsule; oral



  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: September 11, 1984

    Strength(s): EQ 100MG BASE [AB], EQ 50MG BASE [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: July 10, 1986

    Strength(s): EQ 100MG BASE [AB], EQ 50MG BASE [AB]


  • Manufacturer: WATSON LABS FLORIDA

    Approved Prior to Jan 1, 1982

    Strength(s): EQ 100MG BASE [AB]


  • Manufacturer: WATSON LABS FLORIDA

    Approval date: October 13, 1982

    Strength(s): EQ 50MG BASE [AB]


  • Manufacturer: WEST WARD

    Approval date: May 7, 1984

    Strength(s): EQ 100MG BASE [AB]


  • Manufacturer: WEST WARD

    Approval date: November 7, 1984

    Strength(s): EQ 50MG BASE [AB]

Note: No generic formulation of the following product is available.


  • doxycycline calcium - suspension; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vibramycin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Vibramycin.

See also...

  • Vibramycin Consumer Information (Wolters Kluwer)
  • Vibramycin Suspension Consumer Information (Wolters Kluwer)
  • Vibramycin Syrup Consumer Information (Wolters Kluwer)
  • Vibramycin Consumer Information (Cerner Multum)
  • Vibramycin Calcium Consumer Information (Cerner Multum)
  • Vibramycin Monohydrate Consumer Information (Cerner Multum)
  • Vibramycin Calcium Advanced Consumer Information (Micromedex)
  • Vibramycin Monohydrate Advanced Consumer Information (Micromedex)
  • Doxycycline Consumer Information (Drugs.com)
  • Doxycycline Consumer Information (Wolters Kluwer)
  • Doxycycline Capsules Consumer Information (Wolters Kluwer)
  • Doxycycline Hyclate Consumer Information (Wolters Kluwer)
  • Doxycycline Hyclate Delayed-Release Capsules Consumer Information (Wolters Kluwer)
  • Doxycycline Hyclate Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Doxycycline Kit Consumer Information (Wolters Kluwer)
  • Doxycycline Monohydrate Consumer Information (Wolters Kluwer)
  • Doxycycline Suspension Consumer Information (Wolters Kluwer)
  • Doxycycline Syrup Consumer Information (Wolters Kluwer)
  • Doxycycline Tablets Consumer Information (Wolters Kluwer)
  • Doxycycline with Cleanser Consumer Information (Wolters Kluwer)
  • Doxycycline Consumer Information (Cerner Multum)
  • Adoxa Pak Advanced Consumer Information (Micromedex)
  • Atridox Advanced Consumer Information (Micromedex)
  • Vibramycin Hyclate Advanced Consumer Information (Micromedex)
  • Doxycycline Advanced Consumer Information (Micromedex)
  • Doxycycline Subgingival Advanced Consumer Information (Micromedex)
  • Doxycycline AHFS DI Monographs (ASHP)
  • Doxycycline Calcium AHFS DI Monographs (ASHP)
  • Doxycycline Hyclate AHFS DI Monographs (ASHP)
  • Doxycycline Hyclate eent AHFS DI Monographs (ASHP)
  • Doxycycline Monohydrate AHFS DI Monographs (ASHP)

No comments:

Post a Comment